Values of the Immune Activation Markers CD38 and HLA-DR and the Ratio CD4/CD8 According to the Delay of Combined AntiRetroviral Therapy (c-ART) Initiation in Primary HIV-infected Patients (PRIMIMMUNO)
Clinical trial NCT02827227 · COMPLETED
Trial details
- NCT number
- NCT02827227
- Sponsor
- Hospices Civils de Lyon
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-01-01
- Primary completion
- 2016-02-01
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.